Odyssey Health (ODYY) Long-Term Deferred Tax (2014 - 2025)

Odyssey Health (ODYY) recorded quarterly Long-Term Deferred Tax of $12.5 million in Q3 2025, up 2.23% quarter-over-quarter from $12.2 million in Q3 2024, and up 2.23% on a YoY basis from $12.2 million in Q3 2024.

Odyssey Health (ODYY) Long-Term Deferred Tax (2014 - 2025) Analysis & Trends

Odyssey Health's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $12.5 million for Q3 2025.

  • In Q3 2025, Long-Term Deferred Tax rose 2.23% year-over-year to $12.5 million; the TTM figure through Jul 2025 stood at $12.5 million (up 2.23% YoY), while the FY2025 annual figure was $12.5 million, up 2.23% from the prior year.
  • Long-Term Deferred Tax was $12.5 million for Q3 2025 at Odyssey Health, up from $12.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $12.5 million in Q3 2025 to a low of $12.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Odyssey Health - - -

Historic Data

Download Data
DateValue
Jul 31, 2025 12.45 Mn
Jul 31, 2024 12.18 Mn
Apr 30, 2019 349,884.00
Jan 31, 2019 336,492.00
Oct 31, 2018 324,453.00
Apr 30, 2018 275,244.00
Jan 31, 2018 249,496.00
Oct 31, 2017 208,968.00
Jul 31, 2017 275,244.00
Apr 30, 2017 194,240.00
Jan 31, 2017 184,391.00
Oct 31, 2016 155,326.00
Jul 31, 2016 107,030.00
Apr 30, 2016 133,027.00
Jan 31, 2016 130,162.00
Oct 31, 2015 115,778.00
Jul 31, 2015 107,030.00
Jan 31, 2015 84,197.00
Oct 31, 2014 66,004.00
Jul 31, 2014 50,786.00